{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T07:03:08Z","timestamp":1784271788214,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Obes"],"DOI":"10.1038\/s41366-026-02167-3","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T06:06:47Z","timestamp":1784268407000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sleeve gastrectomy induces adipose browning via suppression of Asprosin and activation of the ATF3-Nrf2\/HO-1 axis"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1231-5419","authenticated-orcid":false,"given":"Shuai","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yayan","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziwei","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengli","family":"Zi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8011-7732","authenticated-orcid":false,"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1642-0889","authenticated-orcid":false,"given":"Daorong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"2167_CR1","doi-asserted-by":"publisher","DOI":"10.1080\/23288604.2025.2518797","volume":"11","author":"B McPake","year":"2025","unstructured":"McPake B. Overweight, obesity and diabetes: global trends and a better future? Health Syst reform. 2025;11:2518797.","journal-title":"Health Syst reform"},{"key":"2167_CR2","unstructured":"World Health Organisation. Obesity and overweight: key facts. WHO; 2023."},{"key":"2167_CR3","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.mcna.2017.08.012","volume":"102","author":"KD Hall","year":"2018","unstructured":"Hall KD, Kahan S. Maintenance of lost weight and long-term management of obesity. Med Clin North Am. 2018;102:183\u201397.","journal-title":"Med Clin North Am"},{"key":"2167_CR4","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0140-6736(20)32649-0","volume":"397","author":"G Mingrone","year":"2021","unstructured":"Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Capristo E, et al. Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial. Lancet. 2021;397:293\u2013304.","journal-title":"Lancet"},{"key":"2167_CR5","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.1007\/s11695-021-05456-0","volume":"31","author":"G Chen","year":"2021","unstructured":"Chen G, Zhang GX, Peng BQ, Cheng Z, Du X. Roux-En-Y gastric bypass versus sleeve gastrectomy plus procedures for treatment of morbid obesity: systematic review and meta-analysis. Obes Surg. 2021;31:3303\u201311.","journal-title":"Obes Surg"},{"key":"2167_CR6","doi-asserted-by":"publisher","DOI":"10.1111\/jne.12708","volume":"31","author":"DA Sandoval","year":"2019","unstructured":"Sandoval DA. Mechanisms for the metabolic success of bariatric surgery. J Neuroendocrinol. 2019;31:e12708.","journal-title":"J Neuroendocrinol"},{"key":"2167_CR7","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s00423-023-02821-8","volume":"408","author":"S Latteri","year":"2023","unstructured":"Latteri S, Sofia M, Puleo S, Di Vincenzo A, Cinti S, Castorina S. Mechanisms linking bariatric surgery to adipose tissue, glucose metabolism, fatty liver disease and gut microbiota. Langenbecks Arch Surg. 2023;408:101.","journal-title":"Langenbecks Arch Surg"},{"key":"2167_CR8","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.2337\/db21-0251","volume":"70","author":"R Ben-Haroush Schyr","year":"2021","unstructured":"Ben-Haroush Schyr R, Al-Kurd A, Moalem B, Permyakova A, Israeli H, Bardugo A, et al. Sleeve gastrectomy suppresses hepatic glucose production and increases hepatic insulin clearance independent of weight loss. Diabetes. 2021;70:2289\u201398.","journal-title":"Diabetes"},{"key":"2167_CR9","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.cell.2012.05.016","volume":"150","author":"J Wu","year":"2012","unstructured":"Wu J, Bostr\u00f6m P, Sparks LM, Ye L, Choi JH, Giang AH, et al. Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell. 2012;150:366\u201376.","journal-title":"Cell"},{"key":"2167_CR10","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.cell.2016.02.063","volume":"165","author":"C Romere","year":"2016","unstructured":"Romere C, Duerrschmid C, Bournat J, Constable P, Jain M, Xia F, et al. Asprosin, a fasting-induced glucogenic protein hormone. Cell. 2016;165:566\u201379.","journal-title":"Cell"},{"key":"2167_CR11","doi-asserted-by":"crossref","unstructured":"Mazur-Bialy AI. Asprosin-A fasting-induced, glucogenic, and orexigenic adipokine as a new promising player. Will it be a new factor in the treatment of obesity, diabetes, or infertility? A review of the literature. Nutrients. 2021;13:620.","DOI":"10.3390\/nu13020620"},{"key":"2167_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1101091","volume":"13","author":"M Farrag","year":"2022","unstructured":"Farrag M, Ait Eldjoudi D, Gonz\u00e1lez-Rodr\u00edguez M, Cordero-Barreal A, Ruiz-Fern\u00e1ndez C, Capuozzo M, et al. Asprosin in health and disease, a new glucose sensor with central and peripheral metabolic effects. Front Endocrinol. 2022;13:1101091.","journal-title":"Front Endocrinol"},{"key":"2167_CR13","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/9471583","volume":"2018","author":"Y Wang","year":"2018","unstructured":"Wang Y, Qu H, Xiong X, Qiu Y, Liao Y, Chen Y, et al. Plasma asprosin concentrations are increased in individuals with glucose dysregulation and correlated with insulin resistance and first-phase insulin secretion. Mediat Inflamm. 2018;2018:9471583.","journal-title":"Mediat Inflamm"},{"key":"2167_CR14","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/2521096","volume":"2019","author":"K Ugur","year":"2019","unstructured":"Ugur K, Aydin S. Saliva and blood asprosin hormone concentration associated with obesity. Int J Endocrinol. 2019;2019:2521096.","journal-title":"Int J Endocrinol"},{"key":"2167_CR15","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1002\/oby.23471","volume":"30","author":"H Cantay","year":"2022","unstructured":"Cantay H, Binnetoglu K, Gul HF, Bingol SA. Investigation of serum and adipose tissue levels of asprosin in patients with severe obesity undergoing sleeve gastrectomy. Obesity. 2022;30:1639\u201346.","journal-title":"Obesity"},{"key":"2167_CR16","doi-asserted-by":"publisher","first-page":"556","DOI":"10.3389\/fendo.2020.00556","volume":"11","author":"HC Ku","year":"2020","unstructured":"Ku HC, Cheng CF. Master regulator activating transcription factor 3 (ATF3) in metabolic homeostasis and cancer. Front Endocrinol. 2020;11:556.","journal-title":"Front Endocrinol"},{"key":"2167_CR17","doi-asserted-by":"crossref","unstructured":"Hu S, Zhao X, Li R, Hu C, Wu H, Li J, et al. Activating transcription factor 3, glucolipid metabolism, and metabolic diseases. J Mol Cell Biol. 2023;14:mjac067.","DOI":"10.1093\/jmcb\/mjac067"},{"key":"2167_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102951","volume":"68","author":"M Bauz\u00e1-Thorbr\u00fcgge","year":"2023","unstructured":"Bauz\u00e1-Thorbr\u00fcgge M, Peris E, Zamani S, Micallef P, Paul A, Bartesaghi S, et al. NRF2 is essential for adaptative browning of white adipocytes. Redox Biol. 2023;68:102951.","journal-title":"Redox Biol"},{"key":"2167_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-62124-w","volume":"14","author":"D Lv","year":"2024","unstructured":"Lv D, Wang Z, Meng C, Li Y, Ji S. A study of the relationship between serum asprosin levels and MAFLD in a population undergoing physical examination. Sci Rep. 2024;14:11170.","journal-title":"Sci Rep"},{"key":"2167_CR20","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.2147\/DMSO.S527579","volume":"18","author":"J Ristic","year":"2025","unstructured":"Ristic J, Kodalak S, Peralta-Jim\u00e9nez GA, Moura de Lima MF, Kovacevic M, Masic S, et al. Asprosin levels in adults with type 2 diabetes mellitus and diabetic kidney disease: a systematic review and meta-analysis. Diab, Metab Syndr Obes : targets Ther. 2025;18:2493\u2013506.","journal-title":"Diab, Metab Syndr Obes : targets Ther"},{"key":"2167_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1535668","volume":"16","author":"D Liang","year":"2025","unstructured":"Liang D, Li X, Xiang C, Xu M, Ren Y, Zheng F, et al. The correlation between serum asprosin and type 2 diabetic patients with obesity in the community. Front Endocrinol. 2025;16:1535668.","journal-title":"Front Endocrinol"},{"key":"2167_CR22","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s42003-019-0624-y","volume":"2","author":"CF Cheng","year":"2019","unstructured":"Cheng CF, Ku HC, Cheng JJ, Chao SW, Li HF, Lai PF, et al. Adipocyte browning and resistance to obesity in mice is induced by expression of ATF3. Commun Biol. 2019;2:389.","journal-title":"Commun Biol"},{"key":"2167_CR23","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/s42003-024-06915-x","volume":"7","author":"S Hu","year":"2024","unstructured":"Hu S, Cassim Bawa FN, Zhu Y, Pan X, Wang H, Gopoju R, et al. Loss of adipose ATF3 promotes adipose tissue lipolysis and the development of MASH. Commun Biol. 2024;7:1300.","journal-title":"Commun Biol"},{"key":"2167_CR24","doi-asserted-by":"crossref","unstructured":"Suryaningtyas IT, Lee DS, Je JY. Brown Algae Ecklonia cava extract modulates adipogenesis and browning in 3T3-L1 preadipocytes through HO-1\/Nrf2 signaling. Marine Drugs. 2024;22:330.","DOI":"10.3390\/md22080330"},{"key":"2167_CR25","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3389\/fgene.2019.00435","volume":"10","author":"AP Gureev","year":"2019","unstructured":"Gureev AP, Shaforostova EA, Popov VN. Regulation of mitochondrial biogenesis as a way for active longevity: interaction between the Nrf2 and PGC-1\u03b1 signaling pathways. Front Genet. 2019;10:435.","journal-title":"Front Genet"},{"key":"2167_CR26","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.freeradbiomed.2022.07.013","volume":"189","author":"N Esteras","year":"2022","unstructured":"Esteras N, Abramov AY. Nrf2 as a regulator of mitochondrial function: energy metabolism and beyond. Free Radic Biol Med. 2022;189:136\u201353.","journal-title":"Free Radic Biol Med"},{"key":"2167_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-11-8","volume":"11","author":"KJ Neff","year":"2013","unstructured":"Neff KJ, Olbers T, le Roux CW. Bariatric surgery: the challenges with candidate selection, individualizing treatment and clinical outcomes. BMC Med. 2013;11:8.","journal-title":"BMC Med"},{"key":"2167_CR28","doi-asserted-by":"crossref","unstructured":"Mishra I, Duerrschmid C, Ku Z, He Y, Xie W, Silva ES, et al. Asprosin-neutralizing antibodies as a treatment for metabolic syndrome. eLife. 2021;10:e63784.","DOI":"10.7554\/eLife.63784"},{"key":"2167_CR29","doi-asserted-by":"crossref","unstructured":"Keshavjee SH, Schwenger KJP, Yadav J, Jackson TD, Okrainec A, Allard JP. Factors affecting metabolic outcomes post bariatric surgery: role of adipose tissue. J Clin Med. 2021;10:714.","DOI":"10.3390\/jcm10040714"},{"key":"2167_CR30","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez-Montoro JI, Arranz-Salas I, Guti\u00e9rrez-Repiso C, S\u00e1nchez-Garc\u00eda A, Oca\u00f1a-Wilhelmi L, Pinazo-Bandera JM, et al. Weight Loss After Sleeve Gastrectomy According to Metabolic Dysfunction-Associated Steatotic Liver Disease Stage in Patients with Obesity: A Liver Biopsy-Based Prospective Study. Nutrients. 2024;16:3857.","DOI":"10.3390\/nu16223857"},{"key":"2167_CR31","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.giec.2024.03.004","volume":"34","author":"K Gala","year":"2024","unstructured":"Gala K, Ghusn W, Acosta A. Precision medicine in bariatric procedures. Gastrointest Endosc Clin North Am. 2024;34:765\u201379.","journal-title":"Gastrointest Endosc Clin North Am"}],"container-title":["International Journal of Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41366-026-02167-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41366-026-02167-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41366-026-02167-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T06:06:49Z","timestamp":1784268409000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41366-026-02167-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":31,"alternative-id":["2167"],"URL":"https:\/\/doi.org\/10.1038\/s41366-026-02167-3","relation":{},"ISSN":["0307-0565","1476-5497"],"issn-type":[{"value":"0307-0565","type":"print"},{"value":"1476-5497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"assertion":[{"value":"27 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All animal experiments were approved by the Animal Ethics Committee of Yangzhou University (Approval No.: 202311001). All procedures were conducted in strict accordance with the institutional and national guidelines for the care and use of laboratory animals. Animal welfare was carefully monitored throughout the study to minimize pain and distress. This study was carried out in compliance with the ARRIVE (Animal Research: Reporting of In Vivo Experiments) guidelines.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Ethics"}}]}}